Publication

The expanding role of primary care in cancer control

Rubin, G., Berendsen, A., Crawford, S. M., Dommett, R., Earle, C., Emery, J., Fahey, T., Grassi, L., Grunfeld, E., Gupta, S., Hamilton, W., Hiom, S., Hunter, D., Lyratzopoulos, G., Macleod, U., Mason, R., Mitchell, G., Neal, R. D., Peake, M., Roland, M., Seifert, B., Sisler, J., Sussman, J., Taplin, S., Vedsted, P., Voruganti, T., Walter, F., Wardle, J., Watson, E., Weller, D., Wender, R., Whelan, J., Whitlock, J., Wilkinson, C., de Wit, N. & Zimmermann, C., Sep-2015, In : Lancet Oncology. 16, 12, p. 1231-1272 42 p.

Research output: Contribution to journalArticleAcademicpeer-review

APA

Rubin, G., Berendsen, A., Crawford, S. M., Dommett, R., Earle, C., Emery, J., Fahey, T., Grassi, L., Grunfeld, E., Gupta, S., Hamilton, W., Hiom, S., Hunter, D., Lyratzopoulos, G., Macleod, U., Mason, R., Mitchell, G., Neal, R. D., Peake, M., ... Zimmermann, C. (2015). The expanding role of primary care in cancer control. Lancet Oncology, 16(12), 1231-1272. https://doi.org/10.1016/S1470-2045(15)00205-3

Author

Rubin, Greg ; Berendsen, Annette ; Crawford, S. Michael ; Dommett, Rachel ; Earle, Craig ; Emery, Jon ; Fahey, Tom ; Grassi, Luigi ; Grunfeld, Eva ; Gupta, Sumit ; Hamilton, Willie ; Hiom, Sara ; Hunter, David ; Lyratzopoulos, Georgios ; Macleod, Una ; Mason, Robert ; Mitchell, Geoffrey ; Neal, Richard D. ; Peake, Michael ; Roland, Martin ; Seifert, Bohumil ; Sisler, Jeff ; Sussman, Jonathan ; Taplin, Stephen ; Vedsted, Peter ; Voruganti, Teja ; Walter, Fiona ; Wardle, Jane ; Watson, Eila ; Weller, David ; Wender, Richard ; Whelan, Jeremy ; Whitlock, James ; Wilkinson, Clare ; de Wit, Niek ; Zimmermann, Camilla. / The expanding role of primary care in cancer control. In: Lancet Oncology. 2015 ; Vol. 16, No. 12. pp. 1231-1272.

Harvard

Rubin, G, Berendsen, A, Crawford, SM, Dommett, R, Earle, C, Emery, J, Fahey, T, Grassi, L, Grunfeld, E, Gupta, S, Hamilton, W, Hiom, S, Hunter, D, Lyratzopoulos, G, Macleod, U, Mason, R, Mitchell, G, Neal, RD, Peake, M, Roland, M, Seifert, B, Sisler, J, Sussman, J, Taplin, S, Vedsted, P, Voruganti, T, Walter, F, Wardle, J, Watson, E, Weller, D, Wender, R, Whelan, J, Whitlock, J, Wilkinson, C, de Wit, N & Zimmermann, C 2015, 'The expanding role of primary care in cancer control', Lancet Oncology, vol. 16, no. 12, pp. 1231-1272. https://doi.org/10.1016/S1470-2045(15)00205-3

Standard

The expanding role of primary care in cancer control. / Rubin, Greg; Berendsen, Annette; Crawford, S. Michael; Dommett, Rachel; Earle, Craig; Emery, Jon; Fahey, Tom; Grassi, Luigi; Grunfeld, Eva; Gupta, Sumit; Hamilton, Willie; Hiom, Sara; Hunter, David; Lyratzopoulos, Georgios; Macleod, Una; Mason, Robert; Mitchell, Geoffrey; Neal, Richard D.; Peake, Michael; Roland, Martin; Seifert, Bohumil; Sisler, Jeff; Sussman, Jonathan; Taplin, Stephen; Vedsted, Peter; Voruganti, Teja; Walter, Fiona; Wardle, Jane; Watson, Eila; Weller, David; Wender, Richard; Whelan, Jeremy; Whitlock, James; Wilkinson, Clare; de Wit, Niek; Zimmermann, Camilla.

In: Lancet Oncology, Vol. 16, No. 12, 09.2015, p. 1231-1272.

Research output: Contribution to journalArticleAcademicpeer-review

Vancouver

Rubin G, Berendsen A, Crawford SM, Dommett R, Earle C, Emery J et al. The expanding role of primary care in cancer control. Lancet Oncology. 2015 Sep;16(12):1231-1272. https://doi.org/10.1016/S1470-2045(15)00205-3


BibTeX

@article{9e5bc1576371420ea64d08ae695ac528,
title = "The expanding role of primary care in cancer control",
abstract = "The nature of cancer control is changing, with an increasing emphasis, fuelled by public and political demand, on prevention, early diagnosis, and patient experience during and after treatment. At the same time, primary care is increasingly promoted, by governments and health funders worldwide, as the preferred setting for most health care for reasons of increasing need, to stabilise health-care costs, and to accommodate patient preference for care close to home. It is timely, then, to consider how this expanding role for primary care can work for cancer control, which has long been dominated by highly technical interventions centred on treatment, and in which the contribution of primary care has been largely perceived as marginal. In this Commission, expert opinion from primary care and public health professionals with academic and clinical cancer expertise-from epidemiologists, psychologists, policy makers, and cancer specialists-has contributed to a detailed consideration of the evidence for cancer control provided in primary care and community care settings. Ranging from primary prevention to end-of-life care, the scope for new models of care is explored, and the actions needed to effect change are outlined. The strengths of primary care-its continuous, coordinated, and comprehensive care for individuals and families-are particularly evident in prevention and diagnosis, in shared follow-up and survivorship care, and in end-of-life care. A strong theme of integration of care runs throughout, and its elements (clinical, vertical, and functional) and the tools needed for integrated working are described in detail. All of this change, as it evolves, will need to be underpinned by new research and by continuing and shared multiprofessional development.",
keywords = "RANDOMIZED CONTROLLED-TRIAL, PRIMARY PALLIATIVE CARE, BRIEF ALCOHOL INTERVENTIONS, PRACTICE RESEARCH DATABASE, DECISION-SUPPORT-SYSTEMS, ACUTE ONCOLOGY SERVICE, PRIMARY-HEALTH-CARE, GENERAL-PRACTITIONERS, COLORECTAL-CANCER, FOLLOW-UP",
author = "Greg Rubin and Annette Berendsen and Crawford, {S. Michael} and Rachel Dommett and Craig Earle and Jon Emery and Tom Fahey and Luigi Grassi and Eva Grunfeld and Sumit Gupta and Willie Hamilton and Sara Hiom and David Hunter and Georgios Lyratzopoulos and Una Macleod and Robert Mason and Geoffrey Mitchell and Neal, {Richard D.} and Michael Peake and Martin Roland and Bohumil Seifert and Jeff Sisler and Jonathan Sussman and Stephen Taplin and Peter Vedsted and Teja Voruganti and Fiona Walter and Jane Wardle and Eila Watson and David Weller and Richard Wender and Jeremy Whelan and James Whitlock and Clare Wilkinson and {de Wit}, Niek and Camilla Zimmermann",
year = "2015",
month = sep,
doi = "10.1016/S1470-2045(15)00205-3",
language = "English",
volume = "16",
pages = "1231--1272",
journal = "Lancet Oncology",
issn = "1470-2045",
publisher = "ELSEVIER SCIENCE INC",
number = "12",

}

RIS

TY - JOUR

T1 - The expanding role of primary care in cancer control

AU - Rubin, Greg

AU - Berendsen, Annette

AU - Crawford, S. Michael

AU - Dommett, Rachel

AU - Earle, Craig

AU - Emery, Jon

AU - Fahey, Tom

AU - Grassi, Luigi

AU - Grunfeld, Eva

AU - Gupta, Sumit

AU - Hamilton, Willie

AU - Hiom, Sara

AU - Hunter, David

AU - Lyratzopoulos, Georgios

AU - Macleod, Una

AU - Mason, Robert

AU - Mitchell, Geoffrey

AU - Neal, Richard D.

AU - Peake, Michael

AU - Roland, Martin

AU - Seifert, Bohumil

AU - Sisler, Jeff

AU - Sussman, Jonathan

AU - Taplin, Stephen

AU - Vedsted, Peter

AU - Voruganti, Teja

AU - Walter, Fiona

AU - Wardle, Jane

AU - Watson, Eila

AU - Weller, David

AU - Wender, Richard

AU - Whelan, Jeremy

AU - Whitlock, James

AU - Wilkinson, Clare

AU - de Wit, Niek

AU - Zimmermann, Camilla

PY - 2015/9

Y1 - 2015/9

N2 - The nature of cancer control is changing, with an increasing emphasis, fuelled by public and political demand, on prevention, early diagnosis, and patient experience during and after treatment. At the same time, primary care is increasingly promoted, by governments and health funders worldwide, as the preferred setting for most health care for reasons of increasing need, to stabilise health-care costs, and to accommodate patient preference for care close to home. It is timely, then, to consider how this expanding role for primary care can work for cancer control, which has long been dominated by highly technical interventions centred on treatment, and in which the contribution of primary care has been largely perceived as marginal. In this Commission, expert opinion from primary care and public health professionals with academic and clinical cancer expertise-from epidemiologists, psychologists, policy makers, and cancer specialists-has contributed to a detailed consideration of the evidence for cancer control provided in primary care and community care settings. Ranging from primary prevention to end-of-life care, the scope for new models of care is explored, and the actions needed to effect change are outlined. The strengths of primary care-its continuous, coordinated, and comprehensive care for individuals and families-are particularly evident in prevention and diagnosis, in shared follow-up and survivorship care, and in end-of-life care. A strong theme of integration of care runs throughout, and its elements (clinical, vertical, and functional) and the tools needed for integrated working are described in detail. All of this change, as it evolves, will need to be underpinned by new research and by continuing and shared multiprofessional development.

AB - The nature of cancer control is changing, with an increasing emphasis, fuelled by public and political demand, on prevention, early diagnosis, and patient experience during and after treatment. At the same time, primary care is increasingly promoted, by governments and health funders worldwide, as the preferred setting for most health care for reasons of increasing need, to stabilise health-care costs, and to accommodate patient preference for care close to home. It is timely, then, to consider how this expanding role for primary care can work for cancer control, which has long been dominated by highly technical interventions centred on treatment, and in which the contribution of primary care has been largely perceived as marginal. In this Commission, expert opinion from primary care and public health professionals with academic and clinical cancer expertise-from epidemiologists, psychologists, policy makers, and cancer specialists-has contributed to a detailed consideration of the evidence for cancer control provided in primary care and community care settings. Ranging from primary prevention to end-of-life care, the scope for new models of care is explored, and the actions needed to effect change are outlined. The strengths of primary care-its continuous, coordinated, and comprehensive care for individuals and families-are particularly evident in prevention and diagnosis, in shared follow-up and survivorship care, and in end-of-life care. A strong theme of integration of care runs throughout, and its elements (clinical, vertical, and functional) and the tools needed for integrated working are described in detail. All of this change, as it evolves, will need to be underpinned by new research and by continuing and shared multiprofessional development.

KW - RANDOMIZED CONTROLLED-TRIAL

KW - PRIMARY PALLIATIVE CARE

KW - BRIEF ALCOHOL INTERVENTIONS

KW - PRACTICE RESEARCH DATABASE

KW - DECISION-SUPPORT-SYSTEMS

KW - ACUTE ONCOLOGY SERVICE

KW - PRIMARY-HEALTH-CARE

KW - GENERAL-PRACTITIONERS

KW - COLORECTAL-CANCER

KW - FOLLOW-UP

U2 - 10.1016/S1470-2045(15)00205-3

DO - 10.1016/S1470-2045(15)00205-3

M3 - Article

VL - 16

SP - 1231

EP - 1272

JO - Lancet Oncology

JF - Lancet Oncology

SN - 1470-2045

IS - 12

ER -

ID: 25456115